Thermo Fisher Scientific OCI Foreign Currency Gain (Loss) Arising During Period, Net of Tax decreased by 116.1% to -$58.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 116.1%, from $360.00M to -$58.00M.
Positive values suggest favorable currency movements for the company's international assets, while negative values indicate unfavorable impacts.
This metric measures the net-of-tax gain or loss resulting from foreign currency transactions and the translation of for...
Standard component of Other Comprehensive Income for companies with global footprints.
ms_oci_foreign_currency_arising_during_period_net_of_tax| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$71.00M | -$32.00M | -$23.00M | -$386.00M | -$216.00M | $44.00M | $125.00M | -$112.00M | $456.00M | $346.00M | -$54.00M | $360.00M | -$58.00M |
| QoQ Change | — | +54.9% | +28.1% | <-999% | +44.0% | +120.4% | +184.1% | -189.6% | +507.1% | -24.1% | -115.6% | +766.7% | -116.1% |
| YoY Change | — | — | — | -443.7% | -575.0% | +291.3% | +132.4% | +48.1% | +936.4% | +176.8% | +51.8% | -21.1% | -116.1% |